267 related articles for article (PubMed ID: 27329137)
41. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
[TBL] [Abstract][Full Text] [Related]
42. Report of a family segregating mutations in both the APC and MSH2 genes: juvenile onset of colorectal cancer in a double heterozygote.
Uhrhammer N; Bignon YJ
Int J Colorectal Dis; 2008 Nov; 23(11):1131-5. PubMed ID: 18629513
[TBL] [Abstract][Full Text] [Related]
43. Germline Mutations in FAF1 Are Associated With Hereditary Colorectal Cancer.
Bonjoch L; Franch-Expósito S; Garre P; Belhadj S; Muñoz J; Arnau-Collell C; Díaz-Gay M; Gratacós-Mulleras A; Raimondi G; Esteban-Jurado C; Soares de Lima Y; Herrera-Pariente C; Cuatrecasas M; Ocaña T; Castells A; Fillat C; Capellá G; Balaguer F; Caldés T; Valle L; Castellví-Bel S
Gastroenterology; 2020 Jul; 159(1):227-240.e7. PubMed ID: 32179092
[TBL] [Abstract][Full Text] [Related]
44. Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.
Knopperts AP; Nielsen M; Niessen RC; Tops CM; Jorritsma B; Varkevisser J; Wijnen J; Siezen CL; Heine-Bröring RC; van Kranen HJ; Vos YJ; Westers H; Kampman E; Sijmons RH; Hes FJ
Fam Cancer; 2013 Mar; 12(1):43-50. PubMed ID: 23007840
[TBL] [Abstract][Full Text] [Related]
45. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.
Cleary SP; Cotterchio M; Jenkins MA; Kim H; Bristow R; Green R; Haile R; Hopper JL; LeMarchand L; Lindor N; Parfrey P; Potter J; Younghusband B; Gallinger S
Gastroenterology; 2009 Apr; 136(4):1251-60. PubMed ID: 19245865
[TBL] [Abstract][Full Text] [Related]
46. Candidate predisposing germline copy number variants in early onset colorectal cancer patients.
Brea-Fernandez AJ; Fernandez-Rozadilla C; Alvarez-Barona M; Azuara D; Ginesta MM; Clofent J; de Castro L; Gonzalez D; Andreu M; Bessa X; Llor X; Xicola R; Jover R; Castells A; Castellvi-Bel S; Capella G; Carracedo A; Ruiz-Ponte C
Clin Transl Oncol; 2017 May; 19(5):625-632. PubMed ID: 27888432
[TBL] [Abstract][Full Text] [Related]
47. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.
Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S
Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843
[TBL] [Abstract][Full Text] [Related]
48. Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer.
Timofeeva MN; Kinnersley B; Farrington SM; Whiffin N; Palles C; Svinti V; Lloyd A; Gorman M; Ooi LY; Hosking F; Barclay E; Zgaga L; Dobbins S; Martin L; Theodoratou E; Broderick P; Tenesa A; Smillie C; Grimes G; Hayward C; Campbell A; Porteous D; Deary IJ; Harris SE; Northwood EL; Barrett JH; Smith G; Wolf R; Forman D; Morreau H; Ruano D; Tops C; Wijnen J; Schrumpf M; Boot A; Vasen HF; Hes FJ; van Wezel T; Franke A; Lieb W; Schafmayer C; Hampe J; Buch S; Propping P; Hemminki K; Försti A; Westers H; Hofstra R; Pinheiro M; Pinto C; Teixeira M; Ruiz-Ponte C; Fernández-Rozadilla C; Carracedo A; Castells A; Castellví-Bel S; Campbell H; Bishop DT; Tomlinson IP; Dunlop MG; Houlston RS
Sci Rep; 2015 Nov; 5():16286. PubMed ID: 26553438
[TBL] [Abstract][Full Text] [Related]
49. Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer.
Djursby M; Hansen TVO; Wadt KAW; Madsen MB; Berchtold LA; Lautrup CK; Markholt S; Jensen UB; Krogh LN; Lundsgaard M; Gerdes AM; Nilbert M; Therkildsen C
Hum Genet; 2022 Dec; 141(12):1925-1933. PubMed ID: 35904628
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles.
Küry S; Garrec C; Airaud F; Breheret F; Guibert V; Frenard C; Jiao S; Bonneau D; Berthet P; Bossard C; Ingster O; Cauchin E; Bezieau S
World J Gastroenterol; 2014 Jan; 20(1):204-13. PubMed ID: 24415873
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer.
Fleischmann C; Peto J; Cheadle J; Shah B; Sampson J; Houlston RS
Int J Cancer; 2004 Apr; 109(4):554-8. PubMed ID: 14991577
[TBL] [Abstract][Full Text] [Related]
52. Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers.
Hienonen T; Salovaara R; Mecklin JP; Järvinen H; Karhu A; Aaltonen LA
Int J Cancer; 2006 Jan; 118(2):505-8. PubMed ID: 16049965
[TBL] [Abstract][Full Text] [Related]
53. Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.
Pitroski CE; Cossio SL; Koehler-Santos P; Graudenz M; Prolla JC; Ashton-Prolla P
Int J Colorectal Dis; 2011 Jul; 26(7):841-6. PubMed ID: 21424714
[TBL] [Abstract][Full Text] [Related]
54. Low-penetrance susceptibility variants in familial colorectal cancer.
Niittymäki I; Kaasinen E; Tuupanen S; Karhu A; Järvinen H; Mecklin JP; Tomlinson IP; Di Bernardo MC; Houlston RS; Aaltonen LA
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1478-83. PubMed ID: 20501757
[TBL] [Abstract][Full Text] [Related]
55. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance.
Bellido F; Pineda M; Aiza G; Valdés-Mas R; Navarro M; Puente DA; Pons T; González S; Iglesias S; Darder E; Piñol V; Soto JL; Valencia A; Blanco I; Urioste M; Brunet J; Lázaro C; Capellá G; Puente XS; Valle L
Genet Med; 2016 Apr; 18(4):325-32. PubMed ID: 26133394
[TBL] [Abstract][Full Text] [Related]
56. Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.
Mikaeel RR; Young JP; Li Y; Smith E; Horsnell M; Uylaki W; Tapia Rico G; Poplawski NK; Hardingham JE; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Price TJ
Genes Chromosomes Cancer; 2022 Feb; 61(2):105-113. PubMed ID: 34761457
[TBL] [Abstract][Full Text] [Related]
57.
Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
[TBL] [Abstract][Full Text] [Related]
58. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
59. Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer.
Smith CG; Naven M; Harris R; Colley J; West H; Li N; Liu Y; Adams R; Maughan TS; Nichols L; Kaplan R; Wagner MJ; McLeod HL; Cheadle JP
Hum Mutat; 2013 Jul; 34(7):1026-34. PubMed ID: 23585368
[TBL] [Abstract][Full Text] [Related]
60. Germline variation in O
Belhadj S; Moutinho C; Mur P; Setien F; Llinàs-Arias P; Pérez-Salvia M; Pons T; Pineda M; Brunet J; Navarro M; Capellá G; Esteller M; Valle L
Cancer Lett; 2019 Apr; 447():86-92. PubMed ID: 30677446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
